Research ArticleClinical Studies
Efficacy of Combination Therapy With Radium-223 and Enzalutamide in Castration-resistant Prostate Cancer With Bone Metastases
NAOTO WAKITA, TAKUTO HARA, KOTARO SUZUKI, TOMOAKI TERAKAWA, JUN TEISHIMA, YUZO NAKANO and HIDEAKI MIYAKE
Anticancer Research June 2024, 44 (6) 2627-2635; DOI: https://doi.org/10.21873/anticanres.17069
NAOTO WAKITA
Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan
TAKUTO HARA
Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan
KOTARO SUZUKI
Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan
TOMOAKI TERAKAWA
Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan
JUN TEISHIMA
Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan
YUZO NAKANO
Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan
HIDEAKI MIYAKE
Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan

Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
patientACCESS
patientACCESS - Patients desiring access to articles
In this issue
Efficacy of Combination Therapy With Radium-223 and Enzalutamide in Castration-resistant Prostate Cancer With Bone Metastases
NAOTO WAKITA, TAKUTO HARA, KOTARO SUZUKI, TOMOAKI TERAKAWA, JUN TEISHIMA, YUZO NAKANO, HIDEAKI MIYAKE
Anticancer Research Jun 2024, 44 (6) 2627-2635; DOI: 10.21873/anticanres.17069
Efficacy of Combination Therapy With Radium-223 and Enzalutamide in Castration-resistant Prostate Cancer With Bone Metastases
NAOTO WAKITA, TAKUTO HARA, KOTARO SUZUKI, TOMOAKI TERAKAWA, JUN TEISHIMA, YUZO NAKANO, HIDEAKI MIYAKE
Anticancer Research Jun 2024, 44 (6) 2627-2635; DOI: 10.21873/anticanres.17069





